- marketing/sales sector
-
Health Outcomes Research and Pharmacoeconomics
Optimizing the Global HEOR Function to Drive Product Value in Healthcare and Gaining a Competitive Advantage through Improving Economic Value Consideration
Event Date: 28-29 Jan 2010
Location: Washington DC, USA
- key conference topics
-
- Building a Core Value Proposition Process into Early Product Development by Utilizing a Value-based Approach
- Building Efficient and Effect Market Access Programs to Increase Formulary Potential and Reach Your Target Market
- Evaluating the Phase III Program by Including Key Endpoints that are Relevant for Payers and Needed to Support the Value Proposition
- Discussing the Proposed Legislation on Comparative Effectiveness Research
- Implementing a Long-term Value Platform Throughout the Product Lifecycle
- key conference features
-
- Pre-Conference Workshop Facilitated by Oxford Outcomes
- Patient-Reported Outcomes, Economics and Managed Care: Techniques for Multi-Perspective Health Technology Assessment
- Part I will address the role of patient-reported outcomes (PROs) in health technology assessment (HTA)
- Part II will address the integration of outcomes research and economic analysis in the presentation of materials to health insurance companies and pharmacy benefit managers
- conference focus
-
There has been an increasing pressure to justify and prove the value of key pharmaceutical products while establishing a succe There has been an increasing pressure to justify and prove the value of key pharmaceutical products while establishing a successful strategy to obtain market access, effectively price products, and prove clinical benefits. During an era pending healthcare reform, it is increasingly important to link scientific evidence with pharmacoeconomics and obtain and deliver stronger and more accurate health outcomes; which will impact key decisions in the product life cycle and commercial strategy. Building a core value approach and communicating the value of pharmaceutical products will help overcome access barriers and will aid in promoting effective pricing and reimbursement strategies. Attending this conference will allow you to walk away with key best practices for conducting successful outcomes research and applying pharmacoeconomics deeper into the brand management, product development and commercialization strategies of the pharma industry. It will also provide useful and practical guidance for outreach to healthcare, payer, provider and policy areas and its impact on the current state of the US healthcare system.